Published in Medical Letter on the CDC and FDA, December 10th, 2006
This prospective, multicenter study is designed to collect clinical data and establish the safety and efficacy of the Option Filter in support of both a permanent and retrieval indication. Ten U.S. sites have been selected to participate in this study. Matthew S. Johnson, MD, associate professor of Radiology, Indiana School of Medicine and Chief, Vascular and Interventional Radiology, Clarian Health Partners will be the lead...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA